Back to DE D. E. Shaw & Co., Inc.

ARQTARQT
Showing 8 of 16 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ARCUTIS BIOTHERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 3.9M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $103.6M as of 2026-Q2. The position was increased (+58.2% shares). ARQT represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$103.6M

Current Shares

3.9M

Total Value Change

+$87.3M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.9M
+58.2%
$103.6M0.0%$26.22
43
2026-Q1
Decreased
2.5M
-7.0%
$58.8M0.0%$23.56
0
2025-Q4
Increased
2.7M
+26.6%
$77.9M0.0%$29.04
37
2025-Q3
Decreased
2.1M
-2.0%
$39.9M0.0%$18.85
0
2025-Q2
Increased
2.2M
+8.7%
$30.3M0.0%$14.02
31
2025-Q1
Decreased
2M
-20.9%
$31.1M0.0%$15.64
0
2024-Q4
Increased
2.5M
+44.0%
$35M0.0%$13.93
39
2024-Q3
Increased
1.7M
+73.2%
$16.2M0.0%$9.30
42

Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used